Novel thiourea derivatives against <i>Mycobacterium tuberculosis:</i> synthesis, characterization and molecular docking studies
作者:Emine Kutlu、Fatih Mehmet Emen、Kübra Yıldırım、Cemilenur Ataş、Ruken Esra Demirdogen、Tuncay Yesilkaynak、Neslihan Kaya Kinaytürk、Ece Şimşek、Ahmet Yılmaz Çoban
DOI:10.1080/10426507.2023.2201503
日期:2023.10.3
Abstract N-((2-chloropyridin-3-yl)carbamothioyl)thiophene-2-carboxamide (HL1), N-((6-methylpyridin-2-yl)carbamothioyl)thiophene-2-carboxamide (HL2), N-(allylcarbamothioyl)thiophene-2-carboxamide (HL3), 2-chloro-N-(methyl(1-phenylethyl)carbamothioyl)benzamide (HL4) and 2-chloro-N-(bis((R)-1-phenylethyl)carbamothioyl)benzamide (HL5) were synthesized and characterized via FT-IR, 1H-NMR, 13C-NMR and HR-MS
摘要 N -((2-氯吡啶-3-基)硫氨甲酰基)噻吩-2-甲酰胺 (HL 1 ), N -((6-甲基吡啶-2-基)硫甲酰基)噻吩-2-甲酰胺 (HL 2 ), N - (烯丙基硫代氨基甲酰基)噻吩-2-甲酰胺 (HL 3 )、2-氯-N- (甲基(1-苯乙基)硫代氨基甲酰基)苯甲酰胺 (HL 4 ) 和 2-氯-N- (双((R)-1-苯乙基)合成硫代氨基甲酰基)苯甲酰胺(HL 5 )并通过FT-IR、 1 H-NMR、13 C-NMR和HR-MS技术进行表征, HL 3通过单晶X射线衍射实验对其进行了表征。合成的硫脲衍生物的抗结核活性针对 H37RV(ATCC27294)、ATCC35822(INH 耐药)、ATCC35838(RIF 耐药)、ATCC35820(STM 耐药)和 ATCC35837(EMB 耐药)标准菌株进行了测试。使用微孔板硝酸还原酶测试方法对两种 MDR 和一种主